. In the CLSI system, archived standards are no longer reviewed through the consensus process but remain available for reference. Clinical & Laboratory Standards Institute | CLSI Key Updates in M22-A3
The primary objective of the M22-A3 guideline is to define the responsibilities of both the manufacturer and the end-user laboratory regarding the quality control (QC) of microbiological media. Historically, laboratories were often required to perform extensive "in-house" testing on every batch of commercially prepared media to ensure sterility and growth support. However, M22-A3 identifies specific media with a high history of stability and consistent performance, classifying them as "exempt" from routine user QC testing, provided the manufacturer is compliant with stringent quality standards. This classification allows laboratories to trust the manufacturer’s Certificate of Analysis (CoA) for low-risk media, such as Blood Agar or MacConkey Agar, thereby reducing the consumption of reagents, personnel time, and financial resources. clsi m22a3 pdf link
Offers the CLSI M22-A3 PDF for purchase and provides a free preview of the table of contents and scope. Offers the CLSI M22-A3 PDF for purchase and
Streamlining Microbiology Labs: A Guide to CLSI M22-A3 For microbiology laboratories, maintaining high-quality results starts with the reliability of your culture media. One of the most critical documents guiding this process is CLSI M22-A3 thereby reducing the consumption of reagents
: By identifying "exempt" media, labs can significantly reduce the labor and cost of redundant testing while maintaining high safety standards. Global Consistency
I'm interested in the document M22-A3. Could you please provide information on how I can access this standard? I'd appreciate any guidance on availability or purchase.